Skip to content

Clinical trials

Phase 3 Metabolic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 3 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20043
20057
20064
20076
20088
20092
20103
20114
20121
20137
20144
20161
20171
20181
20192
20202
20211
20222
20232
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status10
Terminated7
Recruiting2
Active, not recruiting2
Enrolling by invitation2
Not yet recruiting2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
University of Erlangen-Nürnberg Medical School3
Centro Universitario de Ciencias de la Salud, Mexico2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
GWT-TUD GmbH2
Kobe University2
Sanofi2
University Hospital, Basel, Switzerland2
University of Saskatchewan2
5 Santé1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome71
Obesity16
Diabetes Mellitus, Type 29
Hypertension7
Insulin Resistance7
Diabetes Mellitus6
Dyslipidemias6
Schizophrenia5
Glucose Intolerance4
Hyperglycemia4

Trials

Showing 76 to 71 of 71. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.